14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for ALKS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.02 2.37 %
R2 24.75 1.26 %
R1 24.58 0.578 %
Current price: 24.44
Support S1 24.04 -1.64 %
S2 23.87 -2.33 %
S3 23.60 -3.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 28.75 17.64 %
R2 26.77 9.53 %
R1 26.73 9.37 %
Current price 24.44
Support S1 24.02 -1.72%
S2 24.01 -1.76%
S3 23.85 -2.41%

ALKS Predictions History

1 year ago
JS predicted that ALKS for 2022-06-06 is going $29.09 (2.65%)

1 year ago
dcplam predicted that ALKS for 2022-06-06 is going

Rank:

4 years ago
NameNotImportant predicted that ALKS for 2019-05-06 is going $28.13 (-1.47%)

4 years ago
joe1234 predicted that ALKS for 2019-05-06 is going $29.11 (2.00%)

4 years ago
NameNotImportant predicted that ALKS for 2019-04-29 is going $31.58 (3.47%)

5 years ago
NameNotImportant predicted that ALKS for 2019-04-22 is going $34.87 (3.84%)

Click to get the best stock tips daily for free!

About Alkermes plc

Alkermes plc Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the tre... ALKS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT